Company Filing History:
8 out of 101 
6 out of 11 
2 out of 810 
Years Active: 1999-2014
Title: Britta Hardy: Innovator in Angiogenesis Research
Introduction
Britta Hardy is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of angiogenesis research, holding a total of 11 patents. Her work focuses on developing innovative methods and compositions that address angiogenesis-related pathologies.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Compositions and methods for inducing angiogenesis." This patent describes an isolated peptide comprising an amino acid sequence HWRR, as set forth by SEQ ID NO:5. The peptide consists of 4 or 5 amino acids and is designed to be used in methods of treating angiogenesis-related pathologies through pharmaceutical compositions.
Career Highlights
Throughout her career, Britta has worked with notable companies such as Mor Research Applications Ltd. and Curetech Ltd. Her expertise in the field has allowed her to make substantial advancements in medical research and treatment options.
Collaborations
Britta has collaborated with several professionals in her field, including Leah Klapper and Annat Raiter. These partnerships have further enhanced her research and development efforts.
Conclusion
Britta Hardy's innovative work in angiogenesis research has led to significant advancements in medical treatments. Her contributions continue to impact the field positively, showcasing her dedication to improving health outcomes.